â– LECTURE OVERVIEW: Delirium Tremens (DTs) is the most severe and life-threatening manifestation of the alcohol withdrawal syndrome.
â– HYPEREXCITABLE NEURAL MECHANISMS:
1. Chronic GABA Drive: Chronic alcohol use continuously stimulates inhibitory GABA-A receptors, prompting down-regulation of these receptors, and continually blocks excitatory NMDA glutamate receptors, prompting up-regulation of NMDA receptors.
2. Abrupt Cessation: When alcohol is abruptly discontinued, the sudden loss of inhibitory GABA stimulation paired with an unregulated glutamatergic drive causes severe, systemic central nervous system hyperexcitability.
3. Autonomic Storm: Drives a severe sympathetic storm, characterized by extreme hypertension, hyperthermia, tachycardic arrhythmias, and psychomotor agitation.
â– BIOCHEMICAL MECHANISMS:
At the molecular level, enzyme kinetics govern reaction rates. Competitive inhibitors raise apparent Michaelis constants without changing maximum speed, whereas noncompetitive inhibitors decrease maximum speed directly.
â– MOLECULAR PATHWAY DYNAMICS:
Intracellular cascades undergo profound modifications, altering secondary transcription levels and receptor presentation on cellular membranes.
[HY-BOARD-1070]
🌟 Dynamic Clinical Key:
DTs typically begins 48-96 hours after the last drink, presenting with altered sensorium, disorientation, and vivid visual/tactile hallucinations (e.g., crawling insects). First-line treatment is aggressive intravenous Benzodiazepines (e.g., Diazepam, Lorazepam) to restore GABAergic inhibition and prevent status epilepticus. Focus on rate-limiting regulatory steps for pharmacological design. Therapeutic molecules targeting upstream signaling components demonstrate superior efficacy profiles.